PRECISEU Best Practice Recognition 2025: Celebrating Europe’s Leaders in Personalised Medicine
Vilnius, 18 September 2025
The PRECISEU consortium proudly announced the winners of the first PRECISEU Best Practice Recognition during Life Sciences Baltics 2025, the leading international event for biotechnology, pharmaceuticals, and medical devices in the Baltic region.
Launched under the Personalised Medicine Empowerment Connecting Innovation ecoSystems across EUROPE (PRECISEU) programme, this initiative honours outstanding practices in personalised medicine and advanced therapies.
It was the perfect opportunity to celebrate projects that pair innovation with inclusivity and real-world impact, turning cutting-edge science into tangible healthcare solutions.
From 68 applications across Europe, four winners were selected by an expert jury, representing excellence in Impact, Innovation, Excellence, and Culture.
Subtitle: The 2025 PRECISEU Best Practice Recognition Winners
IMPACT – DIPCAN (Genomcore, S.L.)
From Insight to Intervention
DIPCAN, powered by GENOMCORE BIMS, accelerates Europe’s ATMP innovation by enabling EHDS-compliant federated data sharing, advanced multimodal AI analytics, and ensuring regulatory trust, driving faster personalized clinical breakthroughs.
Jury statement: “DIPCAN is a project of outstanding quality across nearly all evaluation areas”; ”The DIPCAN project effectively illustrates the translation of a sophisticated data infrastructure into measurable clinical and research outcomes at a national level.”
INNOVATION – OPORA Health
Pushing the Boundaries of What’s Possible
OPORA Health is an AI-ready platform for secure, multimodal brain health data, supporting PTSD care and research in war-affected populations across Ukraine, the UK, and Europe.
Jury statement: “very relevant unmet health need”; ” this project is excellent [..] because it comprehensively matches all criteria of the call”
EXCELLENCE – PragmaTIL (Vall d’Hebron Institute of Oncology)
Harnessing the Power of Data
The PragmaTIL trial aims to optimize TIL-ACT for cancer and enhance its clinical use in academic hospitals.
Jury statement: “[PragmaTIL] has an original concept of decentralized patient care with ATMPs leading to great sustainability”; ”innovative approach to decentralize manufacturing across different countries within a clinical trial”
CULTURE – ENGAGE-ATMP (Sant Joan de Déu Barcelona Children’s Hospital)
Building Trust and Engagement
ENGAGE-ATMP is an innovative, patient-centric translational model for ATMP research and healthcare, to provide holistic, accessible care while empowering patients and caregivers to actively participate in the process.
Jury statement: “Excellent patient-centered methods and perspective”; ”[ENGAGE-ATMP] represents a benchmark in cultural transformation around patient engagement in ATMP research and care. Its long-standing, institutionalized approach demonstrates maturity, inclusivity, and real-world impact, particularly in pediatric rare disease contexts.”
Team: Alessandra Magnani (Fundació Privada Recerca i Docència Sant Joan de Déu, FSJD-CERCA), Joan Vinyets Rejon (Hospital Sant Joan de Déu, HSJD), Begonya Nafria Escalera (FSJD-CERCA)
Subtitle: A milestone for PRECISEU
The awards ceremony took place alongside the PRECISEU General Assembly, where partners reviewed achievements to date and set the Year 2 Action Plan. Together, these activities mark a key milestone in PRECISEU’s mission: strengthening Europe’s capacity to deliver the promise of personalised medicine.
Subtitle: About PRECISEU
PRECISEU is a Horizon Europe project working to connect innovation ecosystems and accelerate the adoption of personalised medicine across Europe, with a strong focus on health data, advanced therapies, and patient engagement. Learn more at www.preciseu.eu.
Subtitle: About Life Sciences Baltics
Life Sciences Baltics is the premier international forum in the Baltics for experts in biotechnology, pharmaceuticals, and medical devices to connect, exchange knowledge, and showcase cutting-edge innovation. More at lifesciencesbaltics.com.
